Shannon James Samuel (CIK 0001485417)

Latest company ownership

Shares held
70,000
Last filed at
Jun 18, 2025
Confidence Score
51.9
2025Q4
Confidence Score History
2025Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 16, 2025 Jun 18, 2025 Xilio Therapeutics, Inc. Director Buy 91.3 +70,000 100.00% ✗ $48.1K